CEL-SCI Corporation CVM

Interesting post from Francis. I,too, am an ENT surgeon. What the trial did prove was ZERO TOXICITY. 5 year survival was improved and there was tumor shrinkage. In a disease where there has been little meaningful improvement in survival with chemotherapy, there was no reason for the FDA not to have given some type of approval. That is what informed consent is for. The Covid vaccine debacle has shown there is corruption within the FDA MK will eventually be approved. It may not be with Geert at the helm bc he has proven to be inept. But with RFL in a cabinet position, eventually this will come across his desk and approval led

Any decent Board would have fired Geert long ago. Without a real Board, CVM investors at mercy of this inept CEO

If GEERT was a believer, he would have 10x that amount.

I want to know why there is no class action lawsuit? Geert is either corrupt or inept. His company has a new class of cancer drug with shows efficacy with ZERO toxicity yet all shareholders get are promises and reverse stock splits. All the while Geert continues to get paid. There should have been either approval or sale after the PIII study was completed. This mismanagement here is epic.

Does everyone think the influence of big pharma is confined to the US? If this drug was successful in Saudi Arabia, do you not think it would eventually damage Keytruda sales in the US. The only thing that will save MK is an activist investor. Geert is inept

Why the need for a confirmatory study for a CANCER drug with ZERO toxicity? Chemotherapy for H&N cancer has not really shown any significant improvement in outcomes for decades.
What other evidence do you need that the FDA is corrupt and patient outcomes are not their 1st priority?

Randy Hart makes many good point which underscores the rot associated with the FDA and MK. Either big pharma (think Keytruda) is stepping on CVM’s neck - perhaps to force a fire sale - or Geert is the most inept/corrupt CEO in all of biotech. Ask yourself who benefitted from the reverse split - certainly not the retail shareholders. A non toxic cancer treatment with any hint of efficacy should have been approved long ago. I do not understand how there has not been some type of class action lawsuit. If for no other reason it would draw attention to the benefits of MK

This is the kind of stock that can bankrupt the shorts.

I do not understand why some of you try to watch charts and trade around this stock. This stock has always been one positive news story from a home run. Why bunt? Few have owned longer than I or understand what a potential breakthrough MK represents. I have been following this story for over 30 years. Geert still deserves a class action suit no matter what happens - esp after the recent reverse split. How do you go from a reverse split of that magnitude to some type of approval within a year.?

Although it is nice to finally see some positive price action, all of us should have 30x more shares. If MK is as groundbreaking as we hope, we would have been at these prices BEFORE the reverse split. Retail investors have been played to finance Geert’s inept (corrupt?) management in bringing this drug to market. Life changing ROI has been reduced to a maybe getting a new car.